Recent Articles

Investing Articles

Should I buy Bloomsbury shares?

I like the look of Bloomsbury Publishing plc (LSE:BMY) for its reliable dividend and growth potential.

Read more »

Investing Articles

£2k to invest for 2020? I’d buy this FTSE 250 stock

I like this FTSE 250 (INDEXFTSE: MCX) stock for 2020 but I'm not so sure about its competitor.

Read more »

Investing Articles

I Like these FTSE 100 plays on cannabis and sustainability

The FTSE 100 (INDEXFTSE: UKX) may not seem to be awash with companies playing the cannabis and sustainability trends, but…

Read more »

Investing Articles

I’m watching this FTSE 250 stock for 2020

I think this FTSE 250 (INDEXFTSE: MCX) stock looks good for 2020.

Read more »

Investing Articles

2 FTSE 100 and FTSE 250 stocks I like for their value and yields

I think the FTSE 100's (INDEXFTSE: UKX) British American Tobacco plc (LSE:BATS) and FTSE 250's (INDEXFTSE: MCX) Britvic plc (LSE:BVIC)…

Read more »

Investing Articles

My top retail shares for August

Good news for UK retailers is faint in a blur of retail gloom but there are two standout stocks I…

Read more »

Investing Articles

Will a no-deal Brexit mean the end for Halfords?

Halfords Group plc (LON:HFD) is the UK’s biggest cycle retailer, but I worry reliance on foreign shipments could be its…

Read more »

Investing Articles

Should I buy Sirius Minerals shares?

Is Sirius Minerals plc (LON:SXX) appealing, or would a 'jam today' stock (that has future potential too) beat its 'jam…

Read more »

Investing Articles

Forget the Sports Direct share price, I think the FTSE 100’s JD Sports has further to climb

Sports Direct International plc (LON:SPD) is a risky bet, but JD Sports Fashion plc (LON:JD) looks safer to me, despite…

Read more »

Investing Articles

Pearson shares dip: why a company data breach is never good for its share price

Another data breach affecting the FTSE 100 is never good news as Pearson plc (LON: PSON) is discovering.

Read more »

Investing Articles

Is the BP share price rise temporary?

BP plc (LON:BP) shares are rising on positive interim results, I wonder if this will continue.

Read more »

Investing Articles

FTSE 100 Hiscox share price dips on interim results. Would I buy?

FTSE 100 (INDEXFTSE: UKX) specialist insurance company Hiscox Ltd (LON: HSX) released mediocre interim results today.

Read more »

Investing Articles

Cobham to be bought in £4bn acquisition, where would I invest my gains?

British defence firm Cobham Plc (LON:COB) is to be acquired by a US private equity firm, so where could your…

Read more »

Investing Articles

Forget ASOS, I think Joules is a better Brexit bet

ASOS plc's (LON:ASC) share price is sliding but I think Joules Group plc (LON:JOUL) is set up for a brighter…

Read more »

Investing Articles

Has this FTSE 100 favourite hit its pinnacle?

This FTSE 100 (INDEXFTSE: UKX) engineering favourite has seen expansion and a rising share price this year, but can it…

Read more »

Investing Articles

Looking to invest in IT? I’m watching this FTSE 250 stock for a dip

I think this FTSE 250 (INDEXFTSE: MCX) IT company, with nine years of profit growth, is worth watching for a…

Read more »

Investing Articles

Is it worth jumping on the bandwagon of SAGA’s rising share price?

Saga plc (LON:SAGA) has been on a slippery slope this year, but could a turnaround be imminent?

Read more »

Investing Articles

A blow to Insurers, but I think these FTSE 100 dividend stocks could be a bargain

Insurance rate cuts disappoint insurers, but I think FTSE 100 (INDEXFTSE: UKX) favourites Admiral and Direct Line remain good buys.

Read more »

Investing Articles

Appetite for Risk? I think these AIM growth stocks are worth watching today

AIM shares are risky, but among them are some potential treasures. I think Altitude Group plc (LSE:ALT) and Ten Lifestyle…

Read more »

Investing Articles

Forget Airbnb income! Why I think a stock portfolio is an easier route to passive income

Airbnb hosting my seem like an easy second income, but I think a stock portfolio is an easier route to…

Read more »

Investing Articles

A FTSE 250 and FTSE 100 insurance stock comparison

Lancashire Holdings Limited (LON:LRE) and FTSE 100 (INDEXFTSE: UKX) stock Hiscox Ltd (LON:HSX) are displaying positive signs of resilience

Read more »

Investing Articles

Is this FTSE 250 stock making a comeback or dead in the water?

I think defence and aerospace heavyweight Cobham plc (LON:COB) is emerging stronger after a disastrous few years, but would I…

Read more »

Investing Articles

Is this Kier competitor stock a bargain?

Kier Group plc (LON:KIE) rival Mitie has gone through some turbulent times, but I think its future looks more promising…

Read more »

Investing Articles

This FTSE 100 stock has grown for 8 years – would I buy now?

I think the size and reputation of Rentokil Initial plc (LON:RTO) mean this FTSE 100 (INDEXFTSE: UKX) stock can continue…

Read more »

Investing Articles

Forget buy-to-let: I prefer this FTSE 250 Stock to give me a slice of the property market

I think Primary Health Properties Plc (LON:PHP) is a FTSE 250 stock with a solid business model and impressive gains.

Read more »

Investing Articles

Forget Kier Group, I’d buy these 2 FTSE 100 shares instead

With the fallout from the demise of Kier Group plc (LON: KIE) still causing the share price to drop, I've…

Read more »

Investing Articles

£5,000 to invest? I’d buy this dividend growth stock today

Cohort plc (LON:CHRT), with its soaring share price, is making all the right decisions.

Read more »

Investing Articles

Forget Ted Baker! I’d buy this FTSE 250 stock instead

With Ted Baker plc (LON: TED) under strain, continued doom and gloom on the high street and share prices falling,…

Read more »

Investing Articles

Dare you buy oil stocks as shipping lanes are threatened?

Political unrest, the threat of oil sanctions and shipping lane blocks are bumping oil share prices. Royal Dutch Shell Plc…

Read more »

Investing Articles

Why I think AstraZeneca is a must-buy dividend stock

A steadily climbing share price, varied product development and positive trial results point to continued success for this big pharma…

Read more »